When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...

The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...

A UK biotechnology startup is entering the crowded obesity drug market, armed with $411 million and a promising ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...